Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Heathrow hails busiest January on record

(Sharecast News) - Heathrow said on Tuesday that it had its busiest January on record, with more than 6.3 million passengers travelling through the airport. This marked a 5% increase on the same month a year ago. The airport also said it was the eleventh month in a row that it averaged more than 200,000 passengers a day, with transatlantic travel a key contributor.

More than 1.2m passengers travelled between the UK and US, up 8% on 2024.

The airport welcomed Chancellor Rachel Reeves' recent show of support for a third runway.

It said that to successfully deliver this project at pace will require policy changes, including on airspace modernisation, planning policy reform and changes to the regulatory regime. Heathrow said it was working with its stakeholders to finalise plans and will submit its proposal to Government by the summer.

Chief executive officer Thomas Woldbye said: "2025 has started how we mean to go on - serving record breaking passenger numbers and delivering trade and investment across the whole of the UK.

"To ensure we continue on this upwards trajectory, the Government has signalled their support for an expanded Heathrow. We'll now work with Ministers to progress the necessary policy changes required to advance our growth plans."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.